HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid.

Abstract
Epigenetic mechanisms underlying nutrition (nutrition epigenetics) are important in understanding human health. Nutritional supplements, for example folic acid, a cofactor in one-carbon metabolism, regulate epigenetic alterations and may play an important role in the maintenance of neuronal integrity. Folic acid also ameliorates hyperhomocysteinemia, which is a consequence of elevated levels of homocysteine. Hyperhomocysteinemia induces oxidative stress that may epigenetically mediate cerebrovascular remodeling and leads to neurodegeneration; however, the mechanisms behind such alterations remain unclear. Therefore, the present study was designed to observe the protective effects of folic acid against hyperhomocysteinemia-induced epigenetic and molecular alterations leading to neurotoxic cascades. To test this hypothesis, we employed 8-weeks-old male wild-type (WT) cystathionine-beta-synthase heterozygote knockout methionine-fed (CBS+/− + Met), WT, and CBS+/− + Met mice supplemented with folic acid (FA) [WT + FA and CBS+/− + Met + FA, respectively, 0.0057-μg g−1 day−1 dose in drinking water/4 weeks]. Hyperhomocysteinemia in CBS+/− + Met mouse brain was accompanied by a decrease in methylenetetrahydrofolate reductase and an increase in S-adenosylhomocysteine hydrolase expression, symptoms of oxidative stress, upregulation of DNA methyltransferases, rise in matrix metalloproteinases, a drop in the tissue inhibitors of metalloproteinases, decreased expression of tight junction proteins, increased permeability of the blood-brain barrier, neurodegeneration, and synaptotoxicity. Supplementation of folic acid to CBS+/− + Met mouse brain led to a decrease in the homocysteine level and rescued pathogenic and epigenetic alterations, showing its protective efficacy against homocysteine-induced neurotoxicity.
AuthorsAnuradha Kalani, Pradip K Kamat, Srikanth Givvimani, Kasey Brown, Naira Metreveli, Suresh C Tyagi, Neetu Tyagi
JournalJournal of molecular neuroscience : MN (J Mol Neurosci) Vol. 52 Issue 2 Pg. 202-15 (Feb 2014) ISSN: 1559-1166 [Electronic] United States
PMID24122186 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Neuroprotective Agents
  • Folic Acid
  • Methionine
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Methyltransferases
  • Adenosylhomocysteinase
  • Matrix Metalloproteinases
  • Cystathionine beta-Synthase
Topics
  • Adenosylhomocysteinase (genetics, metabolism)
  • Animals
  • Blood-Brain Barrier (drug effects, pathology)
  • Cystathionine beta-Synthase (genetics)
  • Diet
  • Epigenesis, Genetic
  • Folic Acid (administration & dosage, pharmacology, therapeutic use)
  • Heterozygote
  • Hyperhomocysteinemia (diet therapy, genetics, metabolism)
  • Matrix Metalloproteinases (genetics, metabolism)
  • Methionine (administration & dosage, pharmacology)
  • Methylenetetrahydrofolate Reductase (NADPH2) (genetics, metabolism)
  • Methyltransferases (genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Neuroprotective Agents (administration & dosage, pharmacology, therapeutic use)
  • Oxidative Stress

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: